Update shared on 09 Dec 2025
Analysts have nudged their price target on Pilgrim's Pride marginally higher to approximately $44.29 per share, reflecting steady expectations for revenue growth, profit margins, and valuation multiples despite only negligible model adjustments.
Valuation Changes
- Fair Value Estimate remains effectively unchanged at approximately $44.29 per share, indicating stable intrinsic value assumptions.
- Discount Rate has fallen slightly, edging down from about 6.96 percent to 6.956 percent, implying a marginally lower required return.
- Revenue Growth has eased fractionally, at about 1.3337 percent with no meaningful change, a shift too small to materially affect the outlook.
- Net Profit Margin is almost unchanged, at roughly 4.3723 percent with no material movement, leaving profitability expectations effectively intact.
- Future P/E multiple has remained essentially steady at about 15.45x, signaling no meaningful shift in valuation multiples.
Have other thoughts on Pilgrim's Pride?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.